United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News LEO Pharma secures global rights to JW1601 in $402m deal with JW Pharmaceutical LEO Pharma, a leading Danish pharmaceutical company, has acquired global exclusive rights to the atopic dermatitis drug JW1601… bypharmanewsdailyAugust 27, 2018